Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
With a market cap of 5.39B, Haemonetics(HAE) trades at $118.51. The stock has a price-to-earnings ratio of 56.66.
As of 2026-10-23, Haemonetics(HAE) stock has fluctuated between $115.49 and $119.20. The current price stands at $118.51, placing the stock +2.6% above today's low and -0.6% off the high.
The Haemonetics(HAE)'s current trading volume is 767.91K, compared to an average daily volume of 697.25K.
During the past year, Haemonetics(HAE) stock moved between $48.98 at its lowest and $123.77 at its peak.
During the past year, Haemonetics(HAE) stock moved between $48.98 at its lowest and $123.77 at its peak.
HAE News
Advertisement FDA approval of PerQseal Elite puts Haemonetics in focus Haemonetics (HAE) is back on investor radar after U.S. regulators cleared its PerQseal...
Analyst Marie Thibault from BTIG maintained a Buy rating on Haemonetics and keeping the price target at $130.00. Marie Thibault has given his Buy rating due to...
Haemonetics (HAE) announced U.S. FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. The approval expands Haemonetics...
Analyst ratings
75%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.